Susquehanna International Group, LLP Nkarta, Inc. Put Options Transaction History

Susquehanna International Group, LLP

6 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	SELL	$4.52 - $8.0 $81,811 - $144,800	-18,100 Reduced 63.96%	10,200 $46,000
Q2 2024 Aug 15, 2024	SELL	$5.27 - $10.82 $349,928 - $718,448	-66,400 Reduced 70.12%	28,300 $167,000
Q1 2024 May 07, 2024	BUY	$5.59 - $15.71 $392,418 - $1.1 Million	70,200 Added 286.53%	94,700 $1.02 Million
Q4 2023 Feb 14, 2024	BUY	$1.31 - $6.6 $32,095 - $161,700	24,500 New	24,500 $161,000
Q2 2023 Aug 11, 2023	BUY	$2.19 - $5.17 $39,858 - $94,094	18,200 New	18,200 $39,000
Q3 2022 Nov 14, 2022	SELL	$12.27 - $18.39 $20,859 - $31,263	-1,700 Reduced 7.39%	21,300 $280,000

129

66.5M

173K

20K

Ticker NKTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,656,800
Market Cap $112M
Description
Nkarta, Inc., a a clinical-stage biopharmaceutical company, develops and commercializes cell therapies for cancer treatment. The company's approach for cellular immunotherapy involves chimeric antigen receptors on the surface of a natural killer (NK) cell that enable the cell to recognize specific proteins or antigens that are present on the sur...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.